Latest Reimbursement News

Aroa Biosurgery delivered a breakout FY26 with NZ$104 million revenue, driven by strong Myriad sales and clinical trial success, setting the stage for ambitious FY27 growth.

Lumos Diagnostics has received a A$709,837 cash refund from the Australian Government’s R&D Tax Incentive, bolstering its investment in proprietary point-of-care diagnostic technologies.

4DMedical has cleared a major regulatory hurdle with the Therapeutic Goods Administration approving its CT:VQ™ lung imaging software, paving the way for commercial use across Australia and strengthening its global footprint.

Swoop Holdings has agreed to sell its Melbourne Fibre Project subsidiary to Singapore-based Xenith Infrastructure Group for $11 million plus project cost reimbursements. The deal offloads remaining capital commitments and will help reduce Swoop’s debt.

Pacific Edge reported a $35.8 million loss in FY26 amid a 47% revenue drop following Medicare coverage loss, but a draft Medicare policy and $36.1 million capital raise set the stage for recovery.

Echo IQ has locked in a binding Heads of Agreement with Pro Medicus for a strategic A$20 million investment and a US commercial partnership to accelerate adoption of its AI-powered cardiac diagnostic platform.

Matsa Resources has received the last $1.65 million option instalment from AngloGold Ashanti, bringing total payments to $9.5 million under their Lake Carey project agreement. AngloGold Ashanti must decide by December whether to exercise the $101 million option.

Woodside Energy has exercised its pre-emption right to acquire PetroChina's 10.67% interest in the Browse Joint Venture, increasing its stake to 41.27%. The deal includes a $225 million upfront payment and a $175 million contingent payment tied to a final investment decision by 2032.

EBR Systems has kicked off a fully underwritten 1-for-2 entitlement offer priced at $0.38 per CDI, aiming to raise $85.6 million to accelerate commercialisation and manufacturing of its wireless cardiac pacing technology.

Emyria Limited is progressing its national network of psychedelic-assisted therapy clinics, reporting durable patient outcomes, expanding funding sources, and benefiting from regulatory changes that broaden therapist eligibility.

Diatreme Resources has finalised the sale of its Cape Flattery Silica Project to a joint venture with Sibelco, receiving $2.1 million in reimbursements and positioning for up to $7.4 million in total funding.

EBR Systems has secured a significant regulatory milestone as the US Centers for Medicare & Medicaid Services (CMS) initiates a National Coverage Determination (NCD) for its WiSE wireless cardiac pacing system, aiming for approval by early 2027.